{"id":646,"date":"2026-05-26T02:35:13","date_gmt":"2026-05-26T06:35:13","guid":{"rendered":"https:\/\/webdirectms.com\/glp\/?p=646"},"modified":"2026-06-06T12:56:02","modified_gmt":"2026-06-06T16:56:02","slug":"the-ultimate-guide-to-soliqua-100-33-combination-therapy-for-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/webdirectms.com\/trimix\/the-ultimate-guide-to-soliqua-100-33-combination-therapy-for-type-2-diabetes\/","title":{"rendered":"The Ultimate Guide to Soliqua 100\/33: Combination Therapy for Type 2 Diabetes"},"content":{"rendered":"\n

Managing type 2 diabetes can become more complicated over time. Some patients eventually need more than one medication strategy to keep fasting blood sugar and after-meal glucose spikes under better control.<\/p>\n\n\n\n

Soliqua 100\/33 was designed for that situation. It combines a long-acting insulin with a GLP-1 receptor agonist in one once-daily pen, which can simplify treatment for adults who need both types of support.<\/p>\n\n\n\n

What is Soliqua 100\/33?<\/h1>\n\n\n\n

Soliqua 100\/33 is an FDA-approved prescription injection used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is a fixed-ratio combination therapy, meaning each dose contains two medicines in a set proportion.<\/p>\n\n\n\n

    \n
  1. Insulin glargine, 100 units\/mL: a long-acting basal insulin that helps manage background blood sugar between meals and overnight.<\/li>\n\n\n\n
  2. Lixisenatide, 33 mcg\/mL: a GLP-1 receptor agonist that can help reduce after-meal glucose spikes, partly by slowing stomach emptying.<\/li>\n<\/ol>\n\n\n\n

    How it works<\/h1>\n\n\n\n

    The two ingredients work in different but complementary ways. Insulin glargine helps cover baseline insulin needs throughout the day. Lixisenatide helps blunt the rise in blood sugar after eating and may also support appetite control for some patients.<\/p>\n\n\n\n

      \n
    • Basal insulin support helps reduce excess glucose production, especially during fasting periods.<\/li>\n\n\n\n
    • The GLP-1 component helps slow digestion after meals, which can reduce sharp glucose spikes.<\/li>\n\n\n\n
    • Using one pen may reduce the burden of managing multiple injectable therapies.<\/li>\n<\/ul>\n\n\n\n

      Timing matters<\/h1>\n\n\n\n

      Soliqua is usually taken once daily within the hour before the first meal of the day. It should not be taken after the meal. This timing is important because lixisenatide is short acting and is intended to help with the glucose rise that follows food.<\/p>\n\n\n\n

      Use it exactly as prescribed. Do not change the dose, timing, or frequency without guidance from your clinician.<\/p>\n\n\n\n

      Potential advantages<\/h1>\n\n\n\n
        \n
      • Two therapies in one daily injection.<\/li>\n\n\n\n
      • Helpful for some adults with type 2 diabetes who need both basal insulin support and GLP-1 activity.<\/li>\n\n\n\n
      • May reduce the number of separate pens or injections a patient has to manage.<\/li>\n\n\n\n
      • Dose adjustments are made through the pen under the direction of a healthcare provider.<\/li>\n<\/ul>\n\n\n\n

        Potential downsides and cautions<\/h1>\n\n\n\n
          \n
        • Because it contains insulin, Soliqua can cause low blood sugar, especially if meals are skipped, activity changes suddenly, or other glucose-lowering medicines are used.<\/li>\n\n\n\n
        • It is not a stand-alone weight-loss medication and is not used for cosmetic weight loss.<\/li>\n\n\n\n
        • It should not be combined with another GLP-1 receptor agonist unless a clinician specifically changes the treatment plan.<\/li>\n\n\n\n
        • Because it slows stomach emptying, it may affect how some oral medicines are absorbed. Ask your prescriber or pharmacist how to time important oral medications.<\/li>\n<\/ul>\n\n\n\n

          Dosing basics<\/h1>\n\n\n\n

          Soliqua dosing is based on the insulin glargine component. The pen is designed to deliver doses within a specific range, and the maximum daily dose is 60 units. If a patient needs more than that, a different diabetes regimen may be required.<\/p>\n\n\n\n

          Your provider may adjust the dose based on fasting blood sugar readings, tolerability, and your broader diabetes plan.<\/p>\n\n\n\n

          Frequently asked questions<\/h1>\n\n\n\n

          Can I use Soliqua with Ozempic, Wegovy, Mounjaro, or Zepbound?<\/h2>\n\n\n\n

          Soliqua already contains a GLP-1 receptor agonist. It is generally not used with another GLP-1 product because that can increase side effects and may not be safe. Do not combine them unless your prescriber has specifically directed a transition plan.<\/p>\n\n\n\n

          What if I miss a dose?<\/h2>\n\n\n\n

          Follow the instructions provided with your prescription or contact your healthcare team. Do not take a double dose to make up for a missed dose, because the insulin component can increase the risk of hypoglycemia.<\/p>\n\n\n\n

          The takeaway<\/h1>\n\n\n\n

          Soliqua can be a practical option for adults with type 2 diabetes who need both basal insulin and GLP-1 support in a single daily injection. It is not a general weight-loss drug, and it requires careful dosing because it contains insulin. A clinician should help decide whether it fits your blood sugar patterns, medication history, and safety needs.<\/p>\n\n\n\n

          <\/p>\n","protected":false},"excerpt":{"rendered":"

          Managing type 2 diabetes can become more complicated over time. Some patients eventually need more than one medication strategy to […]<\/p>\n","protected":false},"author":1,"featured_media":1754,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-646","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/posts\/646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/comments?post=646"}],"version-history":[{"count":1,"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/posts\/646\/revisions"}],"predecessor-version":[{"id":647,"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/posts\/646\/revisions\/647"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/media\/1754"}],"wp:attachment":[{"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/media?parent=646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/categories?post=646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/webdirectms.com\/trimix\/wp-json\/wp\/v2\/tags?post=646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}